Biohaven Ltd (NYSE:BHVN) price on Wednesday, May 21, fall -3.38% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $15.70.
A look at the stock’s price movement, the close in the last trading session was $16.25, moving within a range at $15.65 and $16.38. The beta value (5-Year monthly) was 4.184. Turning to its 52-week performance, $55.70 and $14.69 were the 52-week high and 52-week low respectively. Overall, BHVN moved -25.77% over the past month.
Biohaven Ltd’s market cap currently stands at around $1.60 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-May-11.
Turning to the stock’s technical picture we see that short term indicators suggest on average that BHVN is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
7 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 7 recommend BHVN as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
BHVN’s current price about -20.48% and -29.15% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 33.34, while 7-day volatility ratio is 8.73% and 9.82% in the 30-day chart. Further, Biohaven Ltd (BHVN) has a beta value of 3.63, and an average true range (ATR) of 1.90. Analysts have given the company’s stock an average 52-week price target of $60, forecast between a low of $57 and high of $61. Looking at the price targets, the low is -263.06% off current price level while to achieve the yearly target high, price needs to move -288.54%. Nonetheless, investors will most likely welcome a -282.17% jump to $60 which is the analysts’ median price.
If we refocus on Biohaven Ltd (NYSE:BHVN), historical trading data shows that trading volumes averaged 2.68 over the past 10 days and 1.82 million over the past 3 months. The company’s latest data on shares outstanding shows there are 102.10 million shares.
The 12.68% of Biohaven Ltd’s shares are in the hands of company insiders while institutional holders own 88.66% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 7.81 million on 2025-04-30, giving us a short ratio of 3.37. The data shows that as of 2025-04-30 short interest in Biohaven Ltd (BHVN) stood at 864.0 of shares outstanding, with shares short rising to 7.49 million registered in 2025-03-31. Current price change has pushed the stock -57.97% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the BHVN stock continues to rise going into the next quarter.
